These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

724 related articles for article (PubMed ID: 19470045)

  • 21. Dystrophic psoriatic fingernails treated with 1% 5-fluorouracil in a nail penetration-enhancing vehicle: a double-blind study.
    de Jong EM; Menke HE; van Praag MC; van De Kerkhof PC
    Dermatology; 1999; 199(4):313-8. PubMed ID: 10640840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis.
    Cassell SE; Bieber JD; Rich P; Tutuncu ZN; Lee SJ; Kalunian KC; Wu CW; Kavanaugh A
    J Rheumatol; 2007 Jan; 34(1):123-9. PubMed ID: 17216680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the efficacy of methotrexate and cyclosporine therapies on psoriatic nails: a one-blind, randomized study.
    Gümüşel M; Özdemir M; Mevlitoğlu I; Bodur S
    J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1080-4. PubMed ID: 21118309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Narrow spectrum (311 nm) phototherapy in treatment of psoriatic nail].
    Georgian Med News; 2009 Feb; (167):56-9. PubMed ID: 19276472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of systemic treatment agents on psoriatic nails: a comparative study.
    Demirsoy EO; Kıran R; Salman S; Cağlayan C; Aktürk AS; Bayramgurler D; Bilen N
    J Drugs Dermatol; 2013 Sep; 12(9):1039-43. PubMed ID: 24002153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coexistence of onychomycosis in psoriatic nails: a descriptive study.
    Natarajan V; Nath AK; Thappa DM; Singh R; Verma SK
    Indian J Dermatol Venereol Leprol; 2010; 76(6):723. PubMed ID: 21079333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel treatment of nail psoriasis using the intense pulsed light: a one-year follow-up study.
    Tawfik AA
    Dermatol Surg; 2014 Jul; 40(7):763-8. PubMed ID: 25111349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of nail psoriasis with a modified regimen of steroid injections.
    Saleem K; Azim W
    J Coll Physicians Surg Pak; 2008 Feb; 18(2):78-81. PubMed ID: 18454890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement.
    Baran R; Sigurgeirsson B; de Berker D; Kaufmann R; Lecha M; Faergemann J; Kerrouche N; Sidou F
    Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fungal nail infections: diagnosis and management.
    Prescrire Int; 2009 Feb; 18(99):26-30. PubMed ID: 19391293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of nail psoriasis with adalimumab: an open label unblinded study.
    Rigopoulos D; Gregoriou S; Lazaridou E; Belyayeva E; Apalla Z; Makris M; Katsambas A; Ioannides D
    J Eur Acad Dermatol Venereol; 2010 May; 24(5):530-4. PubMed ID: 19807825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methods of outcomes measurement in nail psoriasis.
    Augustin M; Ogilvie A
    Dermatology; 2010; 221 Suppl 1():23-8. PubMed ID: 20733312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of nail lacquer clobetasol efficacy at 0.05%, 1% and 8% in nail psoriasis treatment: prospective, controlled and randomized pilot study.
    Nakamura RC; Abreu Ld; Duque-Estrada B; Tamler C; Leverone AP
    An Bras Dermatol; 2012; 87(2):203-11. PubMed ID: 22570023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy.
    Jiaravuthisan MM; Sasseville D; Vender RB; Murphy F; Muhn CY
    J Am Acad Dermatol; 2007 Jul; 57(1):1-27. PubMed ID: 17572277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ustekinumab improves nail disease in patients with moderate-to-severe psoriasis: results from PHOENIX 1.
    Rich P; Bourcier M; Sofen H; Fakharzadeh S; Wasfi Y; Wang Y; Kerkmann U; Ghislain PD; Poulin Y;
    Br J Dermatol; 2014 Feb; 170(2):398-407. PubMed ID: 24117389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nail Psoriasis.
    Canal-García E; Bosch-Amate X; Belinchón I; Puig L
    Actas Dermosifiliogr; 2022 May; 113(5):481-490. PubMed ID: 35697407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of ustekinumab in nail psoriasis and improvement in nail-associated quality of life in a population treated with ustekinumab for cutaneous psoriasis: an open prospective unblinded study.
    Rigopoulos D; Gregoriou S; Makris M; Ioannides D
    Dermatology; 2011; 223(4):325-9. PubMed ID: 22134046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study.
    Scher RK; Stiller M; Zhu YI
    Cutis; 2001 Nov; 68(5):355-8. PubMed ID: 11766122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis and management of nail psoriasis].
    Sánchez-Regaña M; Umbert P
    Actas Dermosifiliogr; 2008; 99(1):34-43. PubMed ID: 18206085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of severe nail psoriasis with acitretin: an impressive therapeutic result.
    Ricceri F; Pescitelli L; Tripo L; Bassi A; Prignano F
    Dermatol Ther; 2013; 26(1):77-8. PubMed ID: 23384024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.